Xiaochun Fei
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 22
- Cancer-related molecular mechanisms research 6
- Oncology 25
- HER2/EGFR in Cancer Research 10
- Cancer-related Molecular Pathways 5
- Co-authors
- Kunwei Shen (38 shared papers)Xiaosong Chen (33 shared papers)Yan Mao (5 shared papers)Ou Huang (21 shared papers)Weiguo Chen (21 shared papers)Weimin Chai (6 shared papers)Jiayi Wu (21 shared papers)Junqing Wang (9 shared papers)
- Journals
- Scientific Reports (7 papers)PLoS ONE (6 papers)Frontiers in Oncology (5 papers)Journal of Cancer (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaochun Fei
84 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 601
- Oncology 641
- Radiology, Nuclear Medicine and Imaging 318
- Pathology and Forensic Medicine 240
- Immunology 241
Countries citing papers authored by Xiaochun Fei
This map shows the geographic impact of Xiaochun Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Fei more than expected).
Fields of papers citing papers by Xiaochun Fei
This network shows the impact of papers produced by Xiaochun Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Fei. The network helps show where Xiaochun Fei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochun Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 193 | |
| 2 | 2014 | 132 | |
| 3 | 2014 | 130 | |
| 4 | 2012 | 107 | |
| 5 | 2013 | 106 | |
| 6 | 2017 | 98 | |
| 7 | 2016 | 84 | |
| 8 | 2017 | 67 | |
| 9 | 2023 | 57 | |
| 10 | 2017 | 56 | |
| 11 | 2013 | 51 | |
| 12 | 2013 | 51 | |
| 13 | SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c. | 2019 | 46 |
| 14 | 2015 | 45 | |
| 15 | 2016 | 42 | |
| 16 | 2018 | 38 | |
| 17 | 2015 | 37 | |
| 18 | 2015 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2016 | 33 |
About Xiaochun Fei
Xiaochun Fei is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (10 papers), Cancer-related molecular mechanisms research (6 papers), Breast Lesions and Carcinomas (6 papers), MRI in cancer diagnosis (5 papers), Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (5 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Cancer Research (601 citations), Oncology (641 citations), Radiology, Nuclear Medicine and Imaging (318 citations), Pathology and Forensic Medicine (240 citations) and Immunology (241 citations). Xiaochun Fei has collaborated with scholars based in China, United States and France. Frequent co-authors include Kunwei Shen, Xiaosong Chen, Yan Mao, Ou Huang, Weiguo Chen, Weimin Chai, Jiayi Wu, Junqing Wang, Yongjun Chen and Yafen Li. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Oncology, Journal of Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.